For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver.

With proper treatment, regular monitoring, and commitment to lifestyle changes, many patients with heart failure can lead ...

Mesoblast (MESO) said on Thursday it is awaiting the final minutes from the U.S. Food and Drug Administration (FDA) to ...

Heart Failure (HF) might appear in the heart itself, but its cause can be anywhere in the body. Paying close attention to all ...

New guidelines for treating heart failure could save 3,000 lives and prevent 5,500 hospital admissions every year, according ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...